- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04285957
Italian Translation and Transcultural Validation of Frenchay Activity Index and Walking Handicap Classification in Stroke (FAIWHC)
Italian Translation and Transcultural Validation of Two Assessment Tools for Participation in Stroke Survivors: the Frenchay Activity Index and the Walking Handicap Classification (FAIWHC)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Chiara Castagnoli, pt
- Phone Number: 05573931
- Email: ccastagnoli@dongnocchi.it
Study Contact Backup
- Name: Laura Antonucci, MD
- Phone Number: 055793931
- Email: lauraantonucci1@gmail.com
Study Locations
-
-
-
Florence, Italy, 50143
- Fondazione Don Gnocchi
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Pre-test: 10 consecutively recruited post-stroke patients undergoing intensive rehabilitation treatment at the Neurological Rehabilitation Unit, Foundation don Gnocchi Scientific Institute.Inclusion and exclusion criteria listed in the dedicated section.
Validation: 60 post-stroke patients undergoing intensive rehabilitation treatment at the Neurological Rehabilitation Unit, Foundation don Gnocchi Scientific Institue.Inclusion and exclusion criteria listed in the dedicated section. If the following are present: visual and / or hearing disorders; cognitive decline (MMSE <21) and/or severe aphasia, which would limit the patients' understanding of and the reliable answering to the two assessment tools, the interview shall be carried out with a proxy
Description
Pre-test: consecutive recruitment of 10 post-stroke patients undergoing intensive rehabilitation treatment at the Neurological Rehabilitation Unit, Foundation don Gnocchi Scientific Institute.
Inclusion criteria:
- age 18-90;
- stroke occurred within 3 months from enrollment;
- clinical stability (SIC = 0).
Exclusion criteria:
- stroke recurrence;
- visual and / or hearing disorders;
- cognitive decline (MMSE <21) and/or severe aphasia, which would limit the the patients' understanding of and the reliable answering to the two assessment tools
Validation: recruitment of 60 post-stroke patients undergoing intensive rehabilitation treatment at the Neurological Rehabilitation Unit, Foundation don Gnocchi Scientific Institute-
Inclusion criteria:
- age 18-90,
- stroke occurred within 8 months from enrollment;
- clinical stability (SIC = 0).
Criteria for carrying out the interview with a proxy. If a proxy is not available, the patient is excluded:
- visual and / or hearing disorders;
- cognitive decline (MMSE <21) and/or severe aphasia, which would limit the patients' understanding of and the reliable answering to the two assessment tools.
Study Plan
How is the study designed?
Design Details
- Observational Models: Case-Only
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
pre-test Group
Consecutive recruitment of 10 post-stroke patients undergoing intensive rehabilitation treatment at the Neurological Rehabilitation Unit, Foundation don Gnocchi Scientific Institute. Inclusion criteria: age 18-90, stroke occurred within 3 months from enrollment; clinical stability (SIC = 0). The exclusion criteria are: stroke recurrence; visual and / or hearing disorders; cognitive decline (MMSE <21) and/or severe aphasia, which would limit the the patients' understanding of and the reliable answering to the two assessment tools |
Pre-test: Two expert physicians/physical therapist shall be involved in the questionnaire administration (A/B). The questionnaires shall be randomly administered to the patients by one operator at T0 the same test shall be readministered after 1-2 weeks by another operator (T1), blind to the first assessment; the second operator shall also administer the additional measures (SIP and RMI);
Other Names:
|
Validation Group
Recruitment of 60 post-stroke patients undergoing intensive rehabilitation treatment at the Neurological Rehabilitation Unit, Foundation don Gnocchi Scientific Institute.Inclusion criteria: age 18-90, stroke occurred within 8 months from enrollment; clinical stability (SIC = 0).
If the following criteria are present: visual and / or hearing disorders; cognitive decline (MMSE <21) and/or severe aphasia, which would limit the patients' understanding of and the reliable answering to the two assessment tools, the interview shall be carried out with a proxy
|
Validation Two expert physicians shall be involved in the questionnaire administration (A/B).
The questionnaires shall be randomly administered to the patients by one operator at T0 the same test shall be readministered after 1-2 weeks by another operator (T1), blind to the first assessment; the second operator shall also administer the additional measures (SIP and RMI); In case the patient is unable to be interviewed due to aphasia cognitive or sensorial problems, a proxy would be interviewed both at T0 and at T1 (the same proxy would be interviewed both times)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Interrater reliability
Time Frame: 1 year
|
Intraclass Correlation Coefficient >=0,70
|
1 year
|
Internal consistency (FAI)
Time Frame: 1 year
|
Cronbach's alpha>=0,70
|
1 year
|
concurrent validity of FAI against SIP
Time Frame: 1 year
|
Spearman's coefficient >=0.25-0.50
|
1 year
|
concurrent validity of WHC against RMI
Time Frame: 1 year
|
Spearman's coefficient >=0.25-0.50
|
1 year
|
Collaborators and Investigators
Investigators
- Principal Investigator: Francesca Cecchi, Md, Fondazione Don Carlo Gnocchi IRCCS
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- FAIWHC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke Sequelae
-
Rennes University HospitalCompleted
-
Rennes University HospitalRecruiting
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Fondazione Don Carlo Gnocchi OnlusIstituto di Neuroscienze Consiglio Nazionale delle RicercheRecruitingStroke | Stroke SequelaeItaly
-
Dr. Noah Biotech Inc.CompletedStroke | Stroke SequelaeKorea, Republic of
-
University Hospital, BordeauxActive, not recruitingStroke | Stroke SequelaeFrance
-
Transilvania University of BrasovSpitalul Clinic de Psihiatrie si Neurologie BrasovSuspendedStroke SequelaeRomania
-
Vetrea Terveys OyCompleted
-
Universitat Internacional de CatalunyaInstitut Investigacio Sanitaria Pere VirgiliCompleted
Clinical Trials on Questionnaire administration pre test
-
Istanbul Aydın UniversityCompleted
-
Case Comprehensive Cancer CenterTerminated
-
Barts and the London School of Medicine and DentistryCompletedPrecancerous Condition | Health Status UnknownUnited Kingdom
-
Chung Shan Medical UniversityMinistry of Education, TaiwanCompletedPneumonia | Asthma | Pleural Effusion | Breathing Sound | AuscultationTaiwan
-
University of Rochester NCORP Research BaseNational Cancer Institute (NCI)RecruitingChemotherapy-Induced Peripheral NeuropathyUnited States
-
Dana-Farber Cancer InstituteUniversity of Texas Southwestern Medical Center; Barbara Ann Karmanos Cancer...CompletedProstate CancerUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedCervical Carcinoma | Human Papillomavirus Infection | Health Status Unknown | Cervical Intraepithelial Neoplasia Grade 2/3 | Stage 0 Cervical Cancer | Atypical Squamous Cell of Undetermined Significance | Low Grade Cervical Squamous Intraepithelial NeoplasiaUnited States
-
Rhode Island HospitalCenters for Disease Control and Prevention; HRSA/Maternal and Child Health...CompletedBullying | Exposure to Violent EventUnited States
-
Recep Tayyip Erdogan University Training and Research...Completed
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Completed